Supplemental announcement (i) delay in publication of the 2026 annual results; and (ii) continued suspension of trading
Filed with HKEX · Stock code 660 · · 2 pages · English
Summary by 6ix AI
Wai Chun Bio-Technology Ltd. has issued a supplemental announcement regarding a delay in the publication of its annual results and the continued suspension of trading of its shares. The delay is attributed to the unforeseen absence of a finance manager at a major subsidiary, which impacted the audit process. Trading has been suspended since early October and will remain so until the annual results are published, which is now expected by early November.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Wai Chun Bio-Technology Ltd. on 6ix
Earlier from Wai Chun Bio-Technology
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Exchange notice - suspension of trading
- (I) delay in publication of the 2026 annual results; (ii) possible delay in despatch of the 2026 annual report; and (iii) suspension of trading
- (I) inside information; (ii) possible delay in publication of the annual results for the year ended 30 June 2026; and (iii) possible suspension of trading
- Resignation of chief financial officer, company secretary and authorised representative
Follow Wai Chun Bio-Technology into a list and get an email when it puts out news.
Follow Wai Chun Bio-Technology